Amedeo Smart

Free Medical Literature Service


 

Amedeo

Diabetes

  Free Subscription

Articles published in
Am J Manag Care
    January 2025
  1. VILLAVERDE Z, Hinman RH 2nd, Grimes RM
    Physiologic insulin resensitization lowers cost in patients with diabetes and kidney disease.
    Am J Manag Care. 2025;31:e11-e14.
    >> Share

  2. ERNST K, Thompson AN, Bensami A, Choe HM, et al
    Collaboration to transition members to preferred formulary dipeptidyl-peptidase-4 inhibitor.
    Am J Manag Care. 2025;31:20-24.
    >> Share

    December 2024
  3. NEELAND IJ, Rajagopalan S
    A team-based approach to type 2 diabetes and cardiovascular care.
    Am J Manag Care. 2024;30.
    >> Share

  4. HANDELSMAN Y
    Diabetes, cardiorenal, and metabolic multispecialty practice recommendations and early intensive management of cardio-renal-metabolic disease.
    Am J Manag Care. 2024;30.
    >> Share

  5. FERDINAND KC
    An overview of cardiovascular-kidney-metabolic syndrome.
    Am J Manag Care. 2024;30.
    >> Share

    September 2024
  6. BETTS KA, Oberprieler NG, Wu A, James G, et al
    Antihyperglycemic treatment patterns for chronic kidney disease and type 2 diabetes.
    Am J Manag Care. 2024;30:405-412.
    >> Share

    August 2024
  7. HUANG HC, Touchette DR, Tadrous M, Schumock GT, et al
    Adherence patterns 1 year after initiation of SGLT2 inhibitors: results of a national cohort study.
    Am J Manag Care. 2024;30:e226-e232.
    >> Share

    May 2024
  8. POONAWALLA IB, Chung L, Shetler S, Pearce H, et al
    Medication adherence star ratings measures, health care resource utilization, and cost.
    Am J Manag Care. 2024;30:210-217.
    >> Share

  9. NOBLE M, Chen F, Linke S, Dall TM, et al
    Modeling the economic value of cardiometabolic virtual-first care programs.
    Am J Manag Care. 2024;30.
    >> Share

    April 2024
  10. CHOE JH, Xuan S, Goldenberg A, Matian J, et al
    Medication persistence and its impact on type 2 diabetes.
    Am J Manag Care. 2024;30:e124-e134.
    >> Share

  11. KUMAR A, Dowd-Green C, Green R, Stewart R, et al
    Institutional practices for charitable medication access for uninsured patients.
    Am J Manag Care. 2024;30:e135-e139.
    >> Share

    March 2024
  12. HOFFMAN AF, Roberson CL, Cohen P, Jackson VL, et al
    Improving glycemic control in diabetes through virtual interdisciplinary rounds.
    Am J Manag Care. 2024;30:e78-e84.
    >> Share

  13. QUACH J, Midlam C, Sell C, Levin-Scherz J, et al
    Out-of-pocket costs for diabetes medications in employer-sponsored health insurance plans.
    Am J Manag Care. 2024;30:107-108.
    >> Share

  14. LAMONICA LC, Ren J, Jain N, Goldberg ES, et al
    At-home hemoglobin A1c testing during COVID-19 improved glycemic control.
    Am J Manag Care. 2024;30:e73-e77.
    >> Share

  15. LO JC, Chandra M, Yang W, Thompson N, et al
    Challenges of fracture risk assessment in Asian and Black women.
    Am J Manag Care. 2024;30:140-144.
    >> Share

    December 2023
  16. KERR D, Duncan I, Repetto E, Maroun R, et al
    Cost analysis of self-monitoring blood glucose in nonintensively managed type 2 diabetes.
    Am J Manag Care. 2023;29:670-675.
    >> Share

  17. LISS DT, Cherupally M, O'Brien MJ, Kang RH, et al
    Treatment modification after initiating second-line medication for type 2 diabetes.
    Am J Manag Care. 2023;29:661-668.
    >> Share

    November 2023
  18. HUGHES J, Sparkman A, Smith P, McCormack T, et al
    Charitable medication distribution improves care for uninsured patients with diabetes.
    Am J Manag Care. 2023;29:573-575.
    >> Share

    October 2023
  19. TRUONG B, Li Y, Zheng J, Qian J, et al
    Use of second-generation antidiabetic medication among a nationally representative sample.
    Am J Manag Care. 2023;29:e307-e316.
    >> Share

    September 2023
  20. RIGGS KR, Presley CA, Agne AA, Howell CR, et al
    Measuring continuity of care for diabetes: which visits to include?
    Am J Manag Care. 2023;29:e274-e279.
    >> Share

    August 2023
  21. YUN J, Filardo G, Ahuja V, Bowen ME, et al
    Predicting hospital readmission in Medicaid patients with diabetes using administrative and claims data.
    Am J Manag Care. 2023;29:e229-e234.
    >> Share

  22. STOECKER C, Nauman E, Bazzano AN, Price-Haywood EG, et al
    Non-face-to-face care management and service utilization in patients with diabetes.
    Am J Manag Care. 2023;29:417-422.
    >> Share

    June 2023
  23. ZAKERI M, Lewing BD, Contreras J, Sansgiry SS, et al
    Economic burden of nonadherence to standards of diabetes care.
    Am J Manag Care. 2023;29:e176-e183.
    >> Share

  24. COLVIN CL, Akinyelure OP, Rajan M, Safford MM, et al
    Diabetes, gaps in care coordination, and preventable adverse events.
    Am J Manag Care. 2023;29:e162-e168.
    >> Share

  25. TURK MT, Ritchie ND, Jakub K
    Stakeholder analysis: Medicare Diabetes Prevention Program awareness and implementation.
    Am J Manag Care. 2023;29:308-312.
    >> Share

  26. KAMAL KM
    The role of managed care professionals in the management of neovascular age-related macular degeneration and diabetic macular edema.
    Am J Manag Care. 2023;29.
    >> Share

  27. ALMONY A
    Treatment approaches for neovascular age-related macular degeneration and diabetic macular edema.
    Am J Manag Care. 2023;29.
    >> Share

  28. ALMONY A
    Disease burden of neovascular age-related macular degeneration and diabetic macular edema.
    Am J Manag Care. 2023;29.
    >> Share

    April 2023
  29. MILLER-ROSALES C, Brewster AL, Shortell SM, Rodriguez HP, et al
    Multilevel influences on patient engagement and chronic care management.
    Am J Manag Care. 2023;29:196-202.
    >> Share

    February 2023
  30. LEWING BD, Wallick C, To TM, Masters H 3rd, et al
    Outcomes of antiviral treatment for influenza in type 2 diabetes.
    Am J Manag Care. 2023;29:e43-e50.
    >> Share

    January 2023
  31. RODRIGUEZ HP, Ciemins EL, Rubio K, Rattelman C, et al
    Health systems and telemedicine adoption for diabetes and hypertension care.
    Am J Manag Care. 2023;29:42-49.
    >> Share

    December 2022
  32. DATAR M, Ramakrishnan S, Chong J, Montgomery E, et al
    A kidney diagnostic's impact on physician decision-making in diabetic kidney disease.
    Am J Manag Care. 2022;28:654-661.
    >> Share

  33. KYRILLOS J
    Semaglutide 2.4-mg injection as a novel approach for chronic weight management.
    Am J Manag Care. 2022;28.
    >> Share

  34. MASSIE DC, Amaro A, Kaplan M
    Patient well-being and the clinical and economic burdens associated with obesity in the United States.
    Am J Manag Care. 2022;28.
    >> Share

    November 2022
  35. OLOMU A, Tikaria R, Kelly-Blake K, Hart-Davidson W, et al
    Type 2 diabetes patient activation and mHealth interventions decreased cardiovascular disease risk.
    Am J Manag Care. 2022;28:e392-e398.
    >> Share

  36. RAMACHANDRAN S, Zhang Y, Dunn TJ, Goswami S, et al
    Impact of food affordability on diabetes-related preventable hospitalization.
    Am J Manag Care. 2022;28:574-580.
    >> Share

    October 2022
  37. KARPES MATUSEVICH AR, Xavier C, Rasu RS
    Long-term medication adherence and preventive vs reactive care utilization among older adults with diabetes.
    Am J Manag Care. 2022;28:e378-e387.
    >> Share

  38. BAXTER SL, Quackenbush Q, Cerda J, Gregg C, et al
    Implementing clinical informatics tools for primary care-based diabetic retinopathy screening.
    Am J Manag Care. 2022;28:e355-e362.
    >> Share

    September 2022
  39. SHAWAHNA R, Thawabi F, Salah R, Ramadan S, et al
    Pharmaceutical care services for patients with diabetes: a systematic scoping review.
    Am J Manag Care. 2022;28:e339-e346.
    >> Share

  40. BELLIGUND P, Attaway A, Lopez R, Damania D, et al
    Diabetes associated with higher health care utilization and poor outcomes after COPD-related hospitalizations.
    Am J Manag Care. 2022;28:e325-e332.
    >> Share

    August 2022
  41. IYER NN, Shah S, Ganz ML, Dang-Tan T, et al
    Glucose-lowering treatment patterns in patients with diabetic kidney disease.
    Am J Manag Care. 2022;28:e301-e307.
    >> Share

  42. BETTS KA, Song J, Elliott J, Warnock N, et al
    Geographical variation in kidney function testing and associations with health care costs among patients with chronic kidney disease and type 2 diabetes.
    Am J Manag Care. 2022;28.
    >> Share

  43. POCHOPIEN M, Cherney DZI, Drzewiecka A, Folkerts K, et al
    Validation of the FINE-CKD model for future health technology assessments for finerenone in patients with chronic kidney disease and type 2 diabetes.
    Am J Manag Care. 2022;28.
    >> Share

  44. COOK DJ, Cohen K, Deypalan MN
    A data-based foundation for managing hypertension services.
    Am J Manag Care. 2022;28:e282-e288.
    >> Share

  45. NAIR R, Meadows E, Sheer R, Lipkovich I, et al
    Activation, physical activity, and outcomes among individuals with T2D.
    Am J Manag Care. 2022;28:374-380.
    >> Share

    July 2022
  46. MCADAM-MARX C
    Addressing healthcare disparities and managed care considerations with continuous glucose monitoring.
    Am J Manag Care. 2022;28.
    >> Share

  47. GOLDMAN J
    Continuous glucose monitoring metrics: interpretation and integrations.
    Am J Manag Care. 2022;28.
    >> Share

  48. UNGER J
    Continuous glucose monitoring overview: features and evidence.
    Am J Manag Care. 2022;28.
    >> Share

    March 2022
  49. KIM JE
    Exploring neovascular age-related macular degeneration and diabetic macular edema and advances in treatment.
    Am J Manag Care. 2022;28.
    >> Share

  50. LIU Y
    Managed care opportunities and approaches to select treatment for sight preservation.
    Am J Manag Care. 2022;28.
    >> Share

  51. SOLBERG LI, Carlin CS, Peterson KA, Eder M, et al
    Diabetes care quality: do large medical groups perform better?
    Am J Manag Care. 2022;28:101-107.
    >> Share

    December 2021
  52. POCHOPIEN MT, Cherney DZI, Folkerts K, Levy P, et al
    FINE-CKD model to evaluate economic value of finerenone in patients with chronic kidney disease and type 2 diabetes.
    Am J Manag Care. 2021;27.
    >> Share

  53. BETTS KA, Song J, Faust E, Yang K, et al
    Medical costs for managing chronic kidney disease and related complications in patients with chronic kidney disease and type 2 diabetes.
    Am J Manag Care. 2021;27.
    >> Share

  54. FRIED LF, Petruski-Ivleva N, Folkerts K, Schmedt N, et al
    ACE inhibitor or ARB treatment among patients with diabetes and chronic kidney disease.
    Am J Manag Care. 2021;27.
    >> Share

    November 2021
  55. GRUSS I, Firemark A, Papajorgji-Taylor D, Fitzpatrick SL, et al
    Challenges with implementing the Diabetes Prevention Program for Medicare beneficiaries in an integrated health system.
    Am J Manag Care. 2021;27:e400-e403.
    >> Share

  56. MILLER E, Kerr MSD, Roberts GJ, Nabutovsky Y, et al
    Flash CGM associated with event reduction in nonintensive diabetes therapy.
    Am J Manag Care. 2021;27:e372-e377.
    >> Share

    October 2021
  57. ZUPA MF, Piette JD, Stoll SC, Obrosky DS, et al
    Patient and supporter factors affecting engagement with diabetes telehealth.
    Am J Manag Care. 2021;27:409-414.
    >> Share

  58. PANDYA N, Trenery A, Sieradzan R, Gabai C, et al
    Hypoglycemia upon hospital admission from long-term care: health care resource use.
    Am J Manag Care. 2021;27:e349-e354.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016